nitrates has been researched along with Bronchopulmonary Dysplasia in 3 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this prospective study was to determine whether preterm infants with bronchopulmonary dysplasia (BPD) and signs of increased pulmonary artery pressure have a deficiency of plasma arginine (ARG) and systemic nitric oxide (NO) synthesis." | 7.72 | Plasma arginine and urinary nitrate and nitrite excretion in bronchopulmonary dysplasia. ( Boedeker, RH; Gortner, L; Heckmann, M; Kreuder, J; Reiss, I; Riechers, K; Tsikas, D, 2004) |
| "The aim of this prospective study was to determine whether preterm infants with bronchopulmonary dysplasia (BPD) and signs of increased pulmonary artery pressure have a deficiency of plasma arginine (ARG) and systemic nitric oxide (NO) synthesis." | 3.72 | Plasma arginine and urinary nitrate and nitrite excretion in bronchopulmonary dysplasia. ( Boedeker, RH; Gortner, L; Heckmann, M; Kreuder, J; Reiss, I; Riechers, K; Tsikas, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Posencheg, MA | 1 |
| Gow, AJ | 1 |
| Truog, WE | 1 |
| Ballard, RA | 2 |
| Cnaan, A | 1 |
| Golombek, SG | 1 |
| Ballard, PL | 2 |
| Heckmann, M | 1 |
| Kreuder, J | 1 |
| Riechers, K | 1 |
| Tsikas, D | 1 |
| Boedeker, RH | 1 |
| Reiss, I | 1 |
| Gortner, L | 1 |
| Banks, BA | 1 |
| Ischiropoulos, H | 1 |
| McClelland, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Delayed Pulmonary Transition in Extremely Preterm Infants & Bronchopulmonary Dysplasia[NCT03576885] | Phase 1/Phase 2 | 138 participants (Anticipated) | Interventional | 2019-07-15 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for nitrates and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Inhaled nitric oxide in premature infants: effect on tracheal aspirate and plasma nitric oxide metabolites.
Topics: Bronchopulmonary Dysplasia; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Nitrates; N | 2010 |
2 other studies available for nitrates and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Plasma arginine and urinary nitrate and nitrite excretion in bronchopulmonary dysplasia.
Topics: Arginine; Blood Flow Velocity; Bronchopulmonary Dysplasia; Chromatography, Ion Exchange; Echocardiog | 2004 |
Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Female; Humans; Infant, Newborn; Infant, Premature; Male; Nitrates; Oxid | 1998 |